Protara Therapeutics down after pricing $100 mln stock offering

Protara Therapeutics

10/12/2024 13:03

**  Shares of Protara Therapeutics  TARA.O  down 4% at $6.40
before the bell after follow-on priced
  
    ** Co focused on cancer and rare-diseases late Mon  ~16 mln
shares, including ~2.3 mln 
    pre-funded warrants, for gross proceeds of $100 mln
  
    ** Offering price of $6.25 is 6.3% discount to stock's last
sale
  
    ** New York-based firm intends to use net offering proceeds
t
  
    
      
    
  
    ** On Thurs, TARA shares closed up 
    70% at $6.02 after co  TARA-002 helped remove all signs of
cancer in 72% of patients at six months of treatment for  in
mid-stage study
  
    ** Stock ended 
  
    
      
    
  

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))